Alpha Tau Medical annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Alpha Tau Medical reported −$32.8M in free cash flow for fiscal 2025, a decrease of $10.7M from the previous fiscal year.
View full Alpha Tau Medical company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$32.8M | −$10.7M | — | — |
| 2024 | 2024-12-31 | −$22.0M | $2.3M | — | — |
| 2023 | 2023-12-31 | −$24.4M | $424,000 | — | — |
| 2022 | 2022-12-31 | −$24.8M | −$10.0M | — | — |
| 2021 | 2021-12-31 | −$14.7M | −$3.7M | — | — |
| 2020 | 2020-12-31 | −$11.0M | −$2.8M | — | — |
| 2019 | 2019-12-31 | −$8.2M | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Over the last five reported fiscal years, free cash flow declined from −$11.0M to −$32.8M, a net decrease of $21.7M.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Alpha Tau Medical filings at SEC.gov ↗